AlphaYouOA
Insider buying
Orbimed Advisors Llc bought $34.9M of Braveheart Bio, Inc. (BRVE) stock
Orbimed Advisors Llc, Dir, 10% of Braveheart Bio, Inc. (BRVE), bought 1,940,000 shares of BRVE stock worth $34.9M, per an SEC Form 4 filed Aug 11, 2026.
The shares came through a private deal, not the open market.
The trade happened on Aug 7, 2026, 4 days before it was made public.
BRVE has moved -2.7% since the trade date, from $30.00 to $29.20 (Sep 18, 2026 close).
- Traded
- Aug 7, 2026
- Disclosed
- Aug 11, 2026
- Filing delay
- 4 days
- Price since
- -2.7%
- Role
- Dir, 10%
- Source
- SEC Form 4
More BRVE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.